Literature DB >> 7536799

The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity.

H Nakajima1, P Golstein, P A Henkart.   

Abstract

The requirement for target cell nuclei in the two apoptotic death pathways used by cytotoxic lymphocytes was tested using model effector systems in which the granzyme and Fas pathways of target damage are isolated. Mast cell tumors expressing granzymes A and B in addition to cytolysin/perforin lysed tumor target cells about 10-fold more efficiently than comparable effector cells without granzymes. Enucleated cytoplast targets derived from these cells were also lysed with a similar 10-fold effect of granzymes. In contrast to cytoplasts, effector granzyme expression did not influence lysis of red cell targets. The Fas pathway was assessed using the selected cytotoxic T lymphocyte hybridoma subline d11S, which lysed target cells expressing Fas but not those lacking Fas. Similarly, cytoplasts derived from Fas+ but not Fas- cells were also readily lysed by these effector cells. Thus, neither the nucleus itself nor the characteristic apoptotic nuclear damage associated with the two major cell death pathways used by cytotoxic lymphocytes are required for cell death per se.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536799      PMCID: PMC2192010          DOI: 10.1084/jem.181.5.1905

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  A preparative method for obtaining enucleated mammalian cells.

Authors:  M H Wigler; I B Weinstein
Journal:  Biochem Biophys Res Commun       Date:  1975-04-07       Impact factor: 3.575

2.  A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene.

Authors:  J W Shiver; P A Henkart
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

3.  Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes.

Authors:  H Kojima; N Shinohara; S Hanaoka; Y Someya-Shirota; Y Takagaki; H Ohno; T Saito; T Katayama; H Yagita; K Okumura
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

4.  Studies on the mechanism of lymphocyte-mediated cytolysis. X. Enucleated cells as targets for cytotoxic attack.

Authors:  R F Siliciano; C S Henney
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

Review 5.  DNA topoisomerase poisons as antitumor drugs.

Authors:  L F Liu
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

6.  CTL: virus control cells first and cytolytic cells second? DNA fragmentation, apoptosis and the prelytic halt hypothesis.

Authors:  E Martz; D M Howell
Journal:  Immunol Today       Date:  1989-03

Review 7.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

Review 8.  Internal disintegration model of cytotoxic lymphocyte-induced target damage.

Authors:  J H Russell
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

9.  Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors.

Authors:  P A Henkart; P J Millard; C W Reynolds; M P Henkart
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

10.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Authors:  S Yonehara; A Ishii; M Yonehara
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  18 in total

1.  Role of factors downstream of caspases in nuclear disassembly during apoptotic execution.

Authors:  K Samejima; P Villa; W C Earnshaw
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

Review 2.  Mitochondria and apoptosis: HQ or high-security prison?

Authors:  N J Waterhouse; D R Green
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  A proteomic approach for the discovery of protease substrates.

Authors:  Andrew J Bredemeyer; Renate M Lewis; James P Malone; Alan E Davis; Julia Gross; R Reid Townsend; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

4.  Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.

Authors:  M D Jacobsen; M Weil; M C Raff
Journal:  J Cell Biol       Date:  1996-06       Impact factor: 10.539

Review 5.  Looking beneath the surface: the cell death pathway of Fas/APO-1 (CD95).

Authors:  B Z Stanger
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

6.  Cell fusion to study nuclear-cytoplasmic interactions in endothelial cell apoptosis.

Authors:  V A Polunovsky; D H Ingbar; M Peterson; P B Bitterman
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

7.  Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease.

Authors:  F Yang; X Sun; W Beech; B Teter; S Wu; J Sigel; H V Vinters; S A Frautschy; G M Cole
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 8.  Role of protein kinase activity in apoptosis.

Authors:  M F Lavin; D Watters; Q Song
Journal:  Experientia       Date:  1996-10-31

9.  Volatile fatty acid, metabolic by-product of periodontopathic bacteria, induces apoptosis in WEHI 231 and RAJI B lymphoma cells and splenic B cells.

Authors:  T Kurita-Ochiai; K Ochiai; K Fukushima
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 10.  Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis.

Authors:  C A Casiano; E M Tan
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.